From: High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
Authors | Type | n | Dose (Gy) | F/up (months) | LC 5y (%) | CSS 5y (%) | Necrosis (%) | Stenosis (%) | PP (%) |
---|---|---|---|---|---|---|---|---|---|
Chaudhary et al. [16] | LDR | 23 | 50 | 21 | 70 | 0 | 9 | 70 | |
De Crevoisier et al. [12] | LDR | 144 | 65 | 68 | 80(10) | 92(10) | 26 | 29 | 72 |
Crook et al. [17] | LDR/PDR | 67 | 60 | 48 | 87 | 83,6(10) | 12 | 9 | 88 |
Delannes et al. [18] | LDR | 51 | 50-65 | 65 | 86 | 85 | 23 | 45 | 75 |
Kiltie et al. [19] | LDR | 31 | 63.5 | 61.5 | 81 | 85,5 | 8 | 44 | 75 |
Mazeron et al. [20] | LDR | 50 | 60-70 | 36-96 | 78 | 6 | 19 | 74 | |
Rozan et al. [15] | LDR | 184 | 63 | 139 | 86 | 88 | 21 | 45 | 78 |
Soria et al. [14] | LDR | 102 | 61-70 | 111 | 77 | 72 | 1 | 1 | 72 |
Petera J et al. [11] | HDR | 10 | 54* | 20 | 100 (<2y) | 100 (<2y) | 0 | 0 | 100 |
Present serie | HDR | 12 | 36/39** | 27 | 83 | 100 | 9 | 9 | 92 |